What is a preclinical pregnancy loss?

Area of Science:

• Reproductive Medicine
• Infertility Research
• Embryology

Background:

• Assessing factors influencing pregnancy outcomes after in vitro fertilization (IVF) and embryo transfer (ET) is crucial for improving success rates.
• Distinguishing between embryo quality and uterine receptivity in early pregnancy loss is essential for targeted interventions.

Purpose of the Study:

• To determine the contribution of embryo quality to preclinical pregnancy loss rates following IVF/ET.
• To compare preclinical pregnancy loss rates with multiple gestation and clinical loss rates over a three-year period.

Main Methods:

• A retrospective study analyzed pregnancy outcomes from 1675 fresh embryo transfers (ETs) between 1994 and 1997.
• Multiple gestation rates were used as a proxy for embryo quality, while clinical loss rates indicated embryo viability.
• Preclinical pregnancy loss rates were compared against these indicators.

Main Results:

• The overall preclinical pregnancy loss rate was 5% of ETs (17% of pregnancies).
• Pregnancy rates per ET increased significantly (19% to 36%), as did multiple gestation rates (21% to 48%).
• Clinical loss rates decreased (20% to 6%), while preclinical loss rates remained stable (13% to 19%).

Conclusions:

• Preclinical pregnancy loss appears to be more indicative of uterine receptivity issues than embryo quality.
• Recurrent preclinical pregnancy loss after IVF/ET suggests a need to investigate potential uterine abnormalities.